Newsroom | 30974 results

NORTHBROOK, Ill.--(BUSINESS WIRE)--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.145 per share. The dividend will be paid on Sept. 10 to shareholders of record as of the close of business on Aug. 31. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE: ULS) transforms safety, security and sustainability challenges into opportunities for customers in m...

BOSTON--(BUSINESS WIRE)--The Museum of Science, Boston today announced that construction on its new 10,000-square foot civic venue is nearing completion. The William and Charlotte Bloomberg Public Science Common will open to the public on October 10, 2026, followed by a celebratory event on October 28. Designed to inspire lifelong engagement with science by sparking discourse and discovery through immersive experiences around urgent topics including artificial intelligence, climate change, publ...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene (intismeran; V940 or mRNA-4157), a novel investigational mRNA-based individualized neoantigen therapy (INT) being jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck’s a...

CHANTILLY, Va.--(BUSINESS WIRE)--Amentum joins five-year Babcock framework to support nuclear, marine, land, aviation and mission systems for the UK Armed Forces at home and abroad....

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on August 17, 2026, it granted stock options to purchase an aggregate of 70,950 shares of common stock to seven...

ST. LOUIS & DUBLIN, Ohio & MESA, Ariz.--(BUSINESS WIRE)--Gemelli Biotech today announced the publication of a real-world study in Frontiers in Gastroenterology evaluating healthcare resource utilization following IBS-Smart® and Trio-Smart® testing in adults with suspected irritable bowel syndrome (IBS). Gemelli Biotech funded the study and manufactures both tests. IBS is associated with substantial symptom burden and healthcare utilization. The published study suggests that selected use of IBS-...

SAN DIEGO--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, announced today that Dr. Kelly M. Chacón, a nationally recognized reproductive endocrinologist and infertility specialist, has joined the RMA San Diego care team. Dr. Chacón is now seeing patients at RMA’s San Diego clinic, located at 4510 Executive Drive, Suite 150. “Patients come to me at one of the most difficult points in their lives, and it is my privilege to walk with them toward one o...

LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, is celebrating the grand opening of the Colorado Quantum Innovation Center (CQIC), its new facility in Louisville, Colorado at 1315 W. Century Drive. The grand opening coincides with growing recognition of the Boulder–Louisville–Broomfield corridor as "America's Quantum Peak," recognizing the region's concentration of quantum research, talent,...

CHICAGO--(BUSINESS WIRE)--Property Guardian announced the launch of its wildfire risk score built for underwriting real property risks in the Canadian Wildland-Urban Interface....

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today announced the expansion of its analytical services portfolio with standalone analytical capabilities for biotechnology and pharmaceutical clients. The new approach provides access to Cytovance's experienced analytical team and regulatory-ready analytical solutions without requiring a manufacturing engagement. Building on...